Giuseppe Testa
- Head of Neurogenomics
- Research Group Leader, Testa Group
Giuseppe Testa è un medico, professore ordinario di Biologia Molecolare presso l’Università Statale di Milano e Direttore del High Definition Disease Modelling Lab: Stem Cell and Organoid Epigenetics dell’Istituto Europeo di Oncologia. A Human Technopole il prof. Testa guida il centro di Neurogenomica del programma di ricerca in convenzione con l’Università Statale di Milano. Il programma si occupa, fra l’altro, dei meccanismi molecolari alla base delle disabilità intellettive e dell’autismo.
Contatti
Segui
Pubblicazioni
-
06/2020 - Molecular Autism
Copy number variants (CNVs): a powerful tool for iPSC-based modelling of ASD
Patients diagnosed with chromosome microdeletions or duplications, known as copy number variants (CNVs), present a unique opportunity to investigate the relationship between patient genotype and cell phenotype. CNVs have high genetic penetrance and give a good correlation between gene locus and patient clinical phenotype. This is especially effective for the study of patients with neurodevelopmental […]
-
04/2020 - Clinical Genetics
A small 7q11.23 microduplication involving GTF2I in a family with intellectual disability
-
04/2020 - American Journal of Human Genetics
DNA Methylation Signature for EZH2 Functionally Classifies Sequence Variants in Three PRC2 Complex Genes.
Weaver syndrome (WS), an overgrowth/intellectual disability syndrome (OGID), is caused by pathogenic variants in the histone methyltransferase EZH2, which encodes a core component of the Polycomb repressive complex-2 (PRC2). Using genome-wide DNA methylation (DNAm) data for 187 individuals with OGID and 969 control subjects, we show that pathogenic variants in EZH2 generate a highly specific […]
-
01/2020 - Environment International
Statement on advancing the assessment of chemical mixtures and their risks for human health and the environment
Pagina precedente